Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, El Messaoudi S, Otandault A, Canterel-Thouennon L, Busson M, Thierry AR, Martineau P, Pannequin J, Roche S, Sirvent A.

EMBO Mol Med. 2018 Feb 9. pii: e7918. doi: 10.15252/emmm.201707918. [Epub ahead of print]

2.

Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.

Carrié C, Petit L, d'Houdain N, Sauvage N, Cottenceau V, Lafitte M, Foumenteze C, Hisz Q, Menu D, Legeron R, Breilh D, Sztark F.

Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30430-2. doi: 10.1016/j.ijantimicag.2017.11.013. [Epub ahead of print]

PMID:
29180280
3.

Early liver metastases in resectable periampullary cancer: Incidence and risk factors.

Guerard AS, Ayav A, Busby H, Lafitte M, Rousseau H, Laurent V.

Eur J Radiol. 2017 Aug;93:265-272. doi: 10.1016/j.ejrad.2017.06.005. Epub 2017 Jun 9.

PMID:
28668425
4.

Design of a small molecule against an oncogenic noncoding RNA.

Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5898-903. doi: 10.1073/pnas.1523975113. Epub 2016 May 11.

5.

Therapeutic targeting of casein kinase 1δ in breast cancer.

Rosenberg LH, Lafitte M, Quereda V, Grant W, Chen W, Bibian M, Noguchi Y, Fallahi M, Yang C, Chang JC, Roush WR, Cleveland JL, Duckett DR.

Sci Transl Med. 2015 Dec 16;7(318):318ra202. doi: 10.1126/scitranslmed.aac8773.

6.

MDCT features of hepatocellular carcinoma (HCC) in non-cirrhotic liver.

Lafitte M, Laurent V, Soyer P, Ayav A, Balaj C, Petit I, Hossu G.

Diagn Interv Imaging. 2016 Mar;97(3):355-60. doi: 10.1016/j.diii.2015.09.007. Epub 2015 Nov 3.

7.

Identification of an EGFRvIII-JNK2-HGF/c-Met-Signaling Axis Required for Intercellular Crosstalk and Glioblastoma Multiforme Cell Invasion.

Saunders VC, Lafitte M, Adrados I, Quereda V, Feurstein D, Ling Y, Fallahi M, Rosenberg LH, Duckett DR.

Mol Pharmacol. 2015 Dec;88(6):962-9. doi: 10.1124/mol.115.097774. Epub 2015 Oct 9.

8.

High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome.

Lafitte M, Tastet S, Perez P, Serisé MA, Grandoulier AS, Aouizerate B, Sibon I, Capuron L, Couffinhal T.

BMC Cardiovasc Disord. 2015 Mar 18;15:23. doi: 10.1186/s12872-015-0015-3.

9.

Development of an HTS-Compatible Assay for the Discovery of Ulk1 Inhibitors.

Rosenberg LH, Lafitte M, Grant W, Chen W, Cleveland JL, Duckett DR.

J Biomol Screen. 2015 Aug;20(7):913-20. doi: 10.1177/1087057115579391. Epub 2015 Apr 7.

10.

Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugs.

Martin-Latry K, Cazaux J, Lafitte M, Couffinhal T.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1088-92. doi: 10.1002/pds.3608. Epub 2014 Mar 19.

PMID:
24648258
11.

Education and home based training for intermittent claudication: functional effects and quality of life.

Prévost A, Lafitte M, Pucheu Y, Couffinhal T; on behalf the CEPTA educational team.

Eur J Prev Cardiol. 2015 Mar;22(3):373-9. doi: 10.1177/2047487313512217. Epub 2013 Oct 31.

PMID:
24177266
12.

Radiologic-pathologic correlation in liver angiomyolipoma in a 68-year-old woman.

Lafitte M, Ayav A, Bressenot A, Claudon M, Regent D, Laurent V.

Diagn Interv Imaging. 2013 Nov;94(11):1161-4. doi: 10.1016/j.diii.2013.03.004. Epub 2013 Sep 19. No abstract available.

13.

FGFR3 has tumor suppressor properties in cells with epithelial phenotype.

Lafitte M, Moranvillier I, Garcia S, Peuchant E, Iovanna J, Rousseau B, Dubus P, Guyonnet-Dupérat V, Belleannée G, Ramos J, Bedel A, de Verneuil H, Moreau-Gaudry F, Dabernat S.

Mol Cancer. 2013 Jul 31;12:83. doi: 10.1186/1476-4598-12-83.

14.

[Benefit of a short atherosclerosis prevention program on post-stroke vascular risk reduction].

Kazadi A, Sibon I, Lafitte M, Pucheu Y, Renou P, Rouanet F, Couffinhal T.

Rev Neurol (Paris). 2013 Apr;169(4):314-20. doi: 10.1016/j.neurol.2012.09.017. Epub 2013 Feb 21. French.

PMID:
23433881
15.

Comprehensive analysis of PTEN status in breast carcinomas.

Jones N, Bonnet F, Sfar S, Lafitte M, Lafon D, Sierankowski G, Brouste V, Banneau G, Tunon de Lara C, Debled M, MacGrogan G, Longy M, Sevenet N.

Int J Cancer. 2013 Jul 15;133(2):323-34. doi: 10.1002/ijc.28021. Epub 2013 Feb 12.

16.

In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens.

Lafitte M, Rousseau B, Moranvillier I, Taillepierre M, Peuchant E, Guyonnet-Dupérat V, Bedel A, Dubus P, de Verneuil H, Moreau-Gaudry F, Dabernat S.

Mol Cancer. 2012 Oct 22;11:81. doi: 10.1186/1476-4598-11-81.

17.

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.

Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T.

Vasc Health Risk Manag. 2012;8:357-61. doi: 10.2147/VHRM.S29985. Epub 2012 Jun 5. Review.

18.

Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database.

Latry P, Martin-Latry K, Lafitte M, Peter C, Couffinhal T.

EuroIntervention. 2012 Apr;7(12):1413-9. doi: 10.4244/EIJV7I12A221.

19.

Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome.

Lafitte M, Pucheu Y, Latry K, Dijos M, Casassus E, Couffinhal T.

Eur J Prev Cardiol. 2013 Apr;20(2):283-90. doi: 10.1177/2047487311434107. Epub 2012 Jan 6.

PMID:
22345674
20.

Fast track echo of abdominal aortic aneurysm using a real pocket-ultrasound device at bedside.

Dijos M, Pucheux Y, Lafitte M, Réant P, Prevot A, Mignot A, Barandon L, Roques X, Roudaut R, Pilois X, Lafitte S.

Echocardiography. 2012 Mar;29(3):285-90. doi: 10.1111/j.1540-8175.2011.01559.x. Epub 2011 Nov 8.

PMID:
22066817
21.

Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment.

Riedel M, Lafitte M, Pucheu Y, Latry K, Couffinhal T.

Eur J Prev Cardiol. 2012 Oct;19(5):1128-37. doi: 10.1177/1741826711420347. Epub 2011 Sep 7.

PMID:
21900366
22.

Validation of the smallest pocket echoscopic device's diagnostic capabilities in heart investigation.

Lafitte S, Alimazighi N, Reant P, Dijos M, Zaroui A, Mignot A, Lafitte M, Pillois X, Roudaut R, DeMaria A.

Ultrasound Med Biol. 2011 May;37(5):798-804. doi: 10.1016/j.ultrasmedbio.2011.02.010. Epub 2011 Mar 31.

PMID:
21458144
23.

Screening abdominal aorta aneurysm during echocardiography: literature review and proposal for a French nationwide study.

Aboyans V, Kownator S, Lafitte M, Brochet E, Emmerich J, Tribouilloy C, Lafitte S, Ferrini M; Working Group for Vascular Diseases/Thrombosis, French Society of Cardiology; Council of Echocardiography, French Society of Cardiology.

Arch Cardiovasc Dis. 2010 Oct;103(10):552-8. doi: 10.1016/j.acvd.2010.06.003. Epub 2010 Aug 30. Review.

24.

After acute coronary syndrome, diabetic patients with peripheral vascular disease remain at high risk of cardiovascular events despite secondary prevention measures.

Lafitte M, Barandon L, Pucheu Y, Pillois X, Gin H, Bonnet J, Couffinhal T.

Arch Cardiovasc Dis. 2010 Feb;103(2):97-105. doi: 10.1016/j.acvd.2009.12.003. Epub 2010 Feb 16.

25.

Efficacy over time of a short overall atherosclerosis management programme on the reduction of cardiovascular risk in patients after an acute coronary syndrome.

Lafitte M, Pradeau V, Leroux L, Richeboeuf V, Tastet S, Boulon C, Paviot B, Bonnet J, Couffinhal T.

Arch Cardiovasc Dis. 2009 Jan;102(1):51-8. doi: 10.1016/j.acvd.2008.09.014. Epub 2008 Nov 18.

26.

Cerebral embolism from subclinical carotid atherosclerotic lesion in a young woman with inflammatory Crohn disease.

Lafitte M, Debruxelles S, Sibon I, Rouanet F, Couffinhal T.

Eur Heart J. 2009 Mar;30(5):575. doi: 10.1093/eurheartj/ehn496. Epub 2008 Nov 7. No abstract available.

PMID:
18996955
27.

Off-pump coronary artery bypass surgery in very high-risk patients: adjustment and preliminary results.

Barandon L, Richebé P, Munos E, Calderon J, Lafitte M, Lafitte S, Couffinhal T, Roques X.

Interact Cardiovasc Thorac Surg. 2008 Oct;7(5):789-93. doi: 10.1510/icvts.2008.183665. Epub 2008 Jul 18.

PMID:
18641012
28.

Automated function imaging: a new operator-independent strain method for assessing left ventricular function.

Belghitia H, Brette S, Lafitte S, Reant P, Picard F, Serri K, Lafitte M, Courregelongue M, Dos Santos P, Douard H, Roudaut R, DeMaria A.

Arch Cardiovasc Dis. 2008 Mar;101(3):163-9.

29.

Assessing cardiovascular risk factors after coronary artery bypass surgery: value of an aggressive strategy including systematic follow-up.

Barandon L, Calderon J, Lafitte M, Leroux L, Cadusseau JL, Roques X, Couffinhal T.

Arch Cardiovasc Dis. 2008 Mar;101(3):155-62.

30.

An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy.

Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S, Kerouani A, Chalabi H, Dos Santos P, Douard H, Roudaut R.

Am J Cardiol. 2007 Jul 1;100(1):128-32. Epub 2007 May 21.

PMID:
17599454
31.

Characterization of the glycosidic linkage of underivatized disaccharides by interaction with Pb(2+) ions.

Firdoussi AE, Lafitte M, Tortajada J, Kone O, Salpin JY.

J Mass Spectrom. 2007 Aug;42(8):999-1011.

PMID:
17567836
32.

Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance.

Boulon C, Lafitte M, Richeboeuf V, Paviot B, Pradeau V, Coste P, Bonnet J, Couffinhal T.

Am J Cardiol. 2006 Dec 1;98(11):1429-34. Epub 2006 Oct 4.

PMID:
17126644
33.

Towards assessing the sympathovagal balance.

Lafitte MJ, Sauvageot OR, Fevre-Genoulaz M, Zimmermann M.

Med Biol Eng Comput. 2006 Aug;44(8):675-82. Epub 2006 Jul 4.

PMID:
16937209
34.

Dynamic ventricular dyssynchrony: an exercise-echocardiography study.

Lafitte S, Bordachar P, Lafitte M, Garrigue S, Reuter S, Reant P, Serri K, Lebouffos V, Berrhouet M, Jais P, Haissaguerre M, Clementy J, Roudaut R, DeMaria AN.

J Am Coll Cardiol. 2006 Jun 6;47(11):2253-9.

35.

Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy.

Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S.

J Am Coll Cardiol. 2006 Mar 21;47(6):1175-81. Epub 2006 Feb 23.

36.

[Echocardiography and biventricular resynchronisation].

Lafitte S, Serri K, Réant P, Lafitte M, Reuter S, Garrigue S, Bordachar P, Roudaut R.

Arch Mal Coeur Vaiss. 2005 Jun;98 Spec No 3:41-7. Review. French.

PMID:
16007832
37.

[Cardiac manifestations of amyloidosis by deposits of transthyretin and apolipoprotein A1. Report of 3 families].

Lafitte S, Lafitte M, Perron JM, Ennouchi D, Vital C, Roudaut R.

Arch Mal Coeur Vaiss. 2003 Jun;96(6):631-5. French.

PMID:
12868344
38.

[Ambulatory surgery: organization of interventions and care].

Derainne N, Brussot P, Robic J, Detournay MC, Lafitte M, Niemerich B, Denisot L.

Soins Gynecol Obstet Pueric Pediatr. 1994 Oct-Nov;(161-162):8-10. French. No abstract available.

PMID:
7667761

Supplemental Content

Loading ...
Support Center